IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders - IGC Pharma, INC.

Press

Releases

June 9, 2022

IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders

Related Posts

IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer’s Data Harmonization Time by 90% in Representative Workflow

July 9, 2026

IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company

July 7, 2026

IGC Pharma’s AHA Agentic AI Platform Reduces Alzheimer’s Data Harmonization Time by 90% in Representative Workflow

June 23, 2026

CEO Update

IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer’s Data Harmonization Time by 90% in Representative Workflow

July 9, 2026

IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company

July 7, 2026